ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Socio-Economic Objective : Poultry
Field of Research : Veterinary Sciences
Clear All
Filter by Field of Research
Veterinary Sciences (16)
Veterinary Virology (7)
Virology (4)
Animal Protection (Pests and Pathogens) (3)
Veterinary Medicine (3)
Veterinary Microbiology (excl. Virology) (3)
Microbiology (Excl. Virology) (2)
Animal Protection (Pests And Pathogens) (1)
Cellular Interactions (Incl. Adhesion, Matrix, Cell Wall) (1)
Epidemiology (1)
Gene Expression (1)
Genetic Technologies: Transformation, Site-Directed Mutagenesis, Etc. (1)
Immunology (1)
Pathology (1)
Veterinary Epidemiology (1)
Veterinary Immunology (1)
Filter by Socio-Economic Objective
Poultry (16)
Beef Cattle (3)
Pigs (3)
Veterinary Biological Preventatives (e.g. Vaccines) (3)
Eggs (2)
Expanding Knowledge in the Agricultural and Veterinary Sciences (2)
Livestock (2)
Minor livestock (e.g. horses, goats, deer) (2)
Prevention—biologicals (e.g. vaccines) (2)
Diagnostic methods (1)
Diagnostics (1)
Horses (1)
Infectious Diseases (1)
Infectious diseases (1)
Sheep—meat (1)
Filter by Funding Provider
Australian Research Council (16)
Filter by Status
Closed (12)
Active (4)
Filter by Scheme
Discovery Projects (10)
Linkage Projects (4)
ARC Future Fellowships (1)
Discovery Early Career Researcher Award (1)
Filter by Country
Australia (16)
Filter by Australian State/Territory
VIC (15)
NSW (1)
SA (1)
  • Researchers (11)
  • Funded Activities (16)
  • Organisations (11)
  • Funded Activity

    Discovery Early Career Researcher Award - Grant ID: DE140100735

    Funder
    Australian Research Council
    Funding Amount
    $395,204.00
    Summary
    Understanding infectious laryngotracheitis virus recombination. This project will study the factors that lead to recombination between strains of infectious laryngotracheitis virus (ILTV) concomitant with increased virulence. In previous studies of ILTV, two new genotypes of virulent field strains were shown to be independent recombinants derived from distinct attenuated ILTV commercial vaccines. These strains became the dominant field viruses responsible for widespread and severe disease outbre .... Understanding infectious laryngotracheitis virus recombination. This project will study the factors that lead to recombination between strains of infectious laryngotracheitis virus (ILTV) concomitant with increased virulence. In previous studies of ILTV, two new genotypes of virulent field strains were shown to be independent recombinants derived from distinct attenuated ILTV commercial vaccines. These strains became the dominant field viruses responsible for widespread and severe disease outbreaks in Australian poultry flocks. This project will enhance understanding of the conditions that led to these deleterious natural recombination events and enable the industry to avoid the emergence of new virulent field strains in the future.
    Read more Read less
    More information
    Active Funded Activity

    Linkage Projects - Grant ID: LP190100864

    Funder
    Australian Research Council
    Funding Amount
    $390,000.00
    Summary
    Salmonella in poultry: improving vaccine efficacy . The central aim of this project is to increase the antigenicity of aroA mutant Salmonella Typhimurium vaccines, in particular Bioproperties’ Vaxsafe® ST. Increased antigenicity will affect the gut microbiota and stimulate a stronger host immune response improving vaccine efficacy and the duration of protection against S. Typhimurium in poultry. This will ultimately reduce bacterial loads in the farm environment, mitigate downstream contaminatio .... Salmonella in poultry: improving vaccine efficacy . The central aim of this project is to increase the antigenicity of aroA mutant Salmonella Typhimurium vaccines, in particular Bioproperties’ Vaxsafe® ST. Increased antigenicity will affect the gut microbiota and stimulate a stronger host immune response improving vaccine efficacy and the duration of protection against S. Typhimurium in poultry. This will ultimately reduce bacterial loads in the farm environment, mitigate downstream contamination of the food supply chain, and reduce the number of human salmonellosis cases.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0211607

    Funder
    Australian Research Council
    Funding Amount
    $431,263.00
    Summary
    Molecular approaches to solving current and emerging problems in the epidemiology and diagnosis of Marek's disease in Australia. Marek's disease (MD) is a ubiquitous viral disease of chickens that is currently controlled in meat chickens by blanket vaccination of all chickens. However, as has happened overseas, the efficacy of the HVT vaccine being used in Australia is breaking down resulting in subclinical and clinical losses due to MD. To assist industry deal with this situation we propose to .... Molecular approaches to solving current and emerging problems in the epidemiology and diagnosis of Marek's disease in Australia. Marek's disease (MD) is a ubiquitous viral disease of chickens that is currently controlled in meat chickens by blanket vaccination of all chickens. However, as has happened overseas, the efficacy of the HVT vaccine being used in Australia is breaking down resulting in subclinical and clinical losses due to MD. To assist industry deal with this situation we propose to develop novel molecular methods for the quantification of Marek's disease viruses (MDV) in the host and the environment, to use these methods to design effective early monitoring systems for MD in broilers that predict disease and performance outcomes, and to develop an epidemiological model that will predict the spread and severity of MD as failure of vaccinal protection progresses.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP140100480

    Funder
    Australian Research Council
    Funding Amount
    $370,000.00
    Summary
    Linking immunomodulation and latency in alphaherpesvirus infection. Herpesviruses cause major diseases in humans and all domestic animal species. Latency forms a significant part of the evolutionary success of herpesviruses, by enabling transmission of the virus throughout the lifetime of the host. Our work has shown that an alphaherpesvirus protein can divert the host’s immune response to become more antibody-mediated and less T cell-mediated. This study explores the consequences of this immune .... Linking immunomodulation and latency in alphaherpesvirus infection. Herpesviruses cause major diseases in humans and all domestic animal species. Latency forms a significant part of the evolutionary success of herpesviruses, by enabling transmission of the virus throughout the lifetime of the host. Our work has shown that an alphaherpesvirus protein can divert the host’s immune response to become more antibody-mediated and less T cell-mediated. This study explores the consequences of this immune diversion, and examines whether this reduced T cell response enables the development of latent infections. Disrupting the virus-host balance by alterations to this conserved viral protein will enable novel approaches to controlling these economically significant viruses.
    Read more Read less
    More information
    Active Funded Activity

    Discovery Projects - Grant ID: DP180101417

    Funder
    Australian Research Council
    Funding Amount
    $348,214.00
    Summary
    Molecular approaches to limit herpesvirus recombination. This project aims to generate safer attenuated herpesvirus vaccines for use in veterinary medicine by genetically manipulating the herpesvirus genome to reduce virus recombination. Recombination is recognised as a safety concern for a range of attenuated herpesvirus vaccines. This project is expected to generate viruses that have an impaired capacity to recombine with other viruses. These viruses will then be tested as candidate vaccines f .... Molecular approaches to limit herpesvirus recombination. This project aims to generate safer attenuated herpesvirus vaccines for use in veterinary medicine by genetically manipulating the herpesvirus genome to reduce virus recombination. Recombination is recognised as a safety concern for a range of attenuated herpesvirus vaccines. This project is expected to generate viruses that have an impaired capacity to recombine with other viruses. These viruses will then be tested as candidate vaccines for use in veterinary medicine. This offers a new approach to developing safer veterinary vaccines that will benefit our important animal industries.
    Read more Read less
    More information
    Active Funded Activity

    Discovery Projects - Grant ID: DP220102827

    Funder
    Australian Research Council
    Funding Amount
    $616,000.00
    Summary
    Functional identification of vaccine targets in pathogenic mycoplasmas. Mycoplasmas are important bacterial pathogens in domestic animals that are incompletely controlled by current vaccines. As a result current control measures for the diseases they cause rely on ongoing treatment with antibiotics. This project will aim to use functional genomics and metabolomics to determine the function of specific surface proteins of a model mycoplasma to identify targets for novel approaches to vaccines aga .... Functional identification of vaccine targets in pathogenic mycoplasmas. Mycoplasmas are important bacterial pathogens in domestic animals that are incompletely controlled by current vaccines. As a result current control measures for the diseases they cause rely on ongoing treatment with antibiotics. This project will aim to use functional genomics and metabolomics to determine the function of specific surface proteins of a model mycoplasma to identify targets for novel approaches to vaccines against these pathogens, and to then assess the potential for inclusion of these proteins in vaccines. Ultimately this will lead to improved vaccines against these important pathogens, improving agricultural productivity and reducing the use of antibiotics in intensively raised livestock.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0665701

    Funder
    Australian Research Council
    Funding Amount
    $274,000.00
    Summary
    Blocking immune responses: a critical factor in herpesvirus virulence? The horse and poultry industries are two large, primarily rural based livestock production industries that are major contributors to the national economy. The research proposed in this project will improve our understanding of the pathogenesis of two important viral pathogens that are each a significant cost to their respective industry, and thus will ultimately reduce the cost of these two viruses to industry. In addition, .... Blocking immune responses: a critical factor in herpesvirus virulence? The horse and poultry industries are two large, primarily rural based livestock production industries that are major contributors to the national economy. The research proposed in this project will improve our understanding of the pathogenesis of two important viral pathogens that are each a significant cost to their respective industry, and thus will ultimately reduce the cost of these two viruses to industry. In addition, the technology developed during this project would have a global market and may be transferable to other viral pathogens of other domestic species.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0349352

    Funder
    Australian Research Council
    Funding Amount
    $210,000.00
    Summary
    Development of an Attenuated Infectious Laryngotracheitis Virus Vaccine. This project will develop novel methods for identification of genes involved in virulence of the important avian pathogen Infectious Laryngotracheitis Virus and produce an attenuated, antigenically marked infectious laryngotracheitis virus vaccine strain by specific disruption and deletion of two or more genes in the virusÕs genome. Infectious laryngotracheitis is a major disease of chickens throughout the world, but curre .... Development of an Attenuated Infectious Laryngotracheitis Virus Vaccine. This project will develop novel methods for identification of genes involved in virulence of the important avian pathogen Infectious Laryngotracheitis Virus and produce an attenuated, antigenically marked infectious laryngotracheitis virus vaccine strain by specific disruption and deletion of two or more genes in the virusÕs genome. Infectious laryngotracheitis is a major disease of chickens throughout the world, but current vaccines retain some capacity to cause disease. The development of novel attenuated vaccines will thus enhance control of this important disease of poultry.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP130103991

    Funder
    Australian Research Council
    Funding Amount
    $330,000.00
    Summary
    Alphaherpesvirus recombination: safety implications for attenuated Herpesvirus vaccines. Under certain conditions some herpesviruses, including mild vaccine strains, can recombine to generate virulent viruses. Following findings that this occurred naturally between Australian poultry vaccines, with devastating results, this project will study natural herpesvirus recombination with the aim of allowing vaccines to be used more safely.
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP160101105

    Funder
    Australian Research Council
    Funding Amount
    $556,000.00
    Summary
    Optimising the efficacy of mycoplasma vaccines in the field. Optimising the efficacy of mycoplasma vaccines in the field. This project intends to examine the effect of antibiotic treatment, killed vaccines and immunosuppressive viruses on the protective immunity induced by a model novel vaccine against the important poultry pathogen Mycoplasma gallisepticum. The continued circulation of pathogenic mycoplasmas in intensively managed animals is a major animal health problem. Live attenuated vaccin .... Optimising the efficacy of mycoplasma vaccines in the field. Optimising the efficacy of mycoplasma vaccines in the field. This project intends to examine the effect of antibiotic treatment, killed vaccines and immunosuppressive viruses on the protective immunity induced by a model novel vaccine against the important poultry pathogen Mycoplasma gallisepticum. The continued circulation of pathogenic mycoplasmas in intensively managed animals is a major animal health problem. Live attenuated vaccines could reduce disease, but we have limited understanding of the best conditions for their use. This project will generate data to guide both use and development of live mycoplasma vaccines. It is expected to have significant impacts on animal health, welfare and production, and public health by reducing the use of antibiotics to control mycoplasmoses.
    Read more Read less
    More information

    Showing 1-10 of 16 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback